Your browser doesn't support javascript.
loading
Improving economic evaluations in stroke: A report from the ESO Health Economics Working Group.
Cadilhac, Dominique A; Kim, Joosup; Wilson, Alastair; Berge, Eivind; Patel, Anita; Ali, Myzoon; Saver, Jeffrey; Christensen, Hanne; Cuche, Matthieu; Crews, Sean; Wu, Olivia; Provoyeur, Marine; McMeekin, Peter; Durand-Zaleski, Isabelle; Ford, Gary A; Muhlemann, Natalia; Bath, Philip M; Abdul-Rahim, Azmil H; Sunnerhagen, Katharina; Meretoja, Atte; Thijs, Vincent; Weimar, Christian; Massaro, Ayrton; Ranta, Annemarei; Lees, Kennedy R.
Afiliación
  • Cadilhac DA; Stroke and Ageing Research, School of Clinical Sciences at Monash Health, Monash University.
  • Kim J; Stroke Division, the Florey Institute of Neuroscience and Mental Health.
  • Wilson A; Stroke and Ageing Research, School of Clinical Sciences at Monash Health, Monash University.
  • Berge E; Stroke Division, the Florey Institute of Neuroscience and Mental Health.
  • Patel A; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Ali M; Department of Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Saver J; Anita Patel Health Economics Consulting Ltd, London, UK.
  • Christensen H; Centre for Primary Care and Public Health, Queen Mary University of London, London, UK.
  • Cuche M; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Crews S; Nursing, Midwifery and Allied Health Professions Research Unit, Glasgow Caledonian University, Glasgow, UK.
  • Wu O; Comprehensive Stroke Center and Department of Neurology, University of California, Los Angeles, CA, USA.
  • Provoyeur M; Bispebjerg Hospital and University of Copenhagen, Copenhagen, Denmark.
  • McMeekin P; Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
  • Durand-Zaleski I; Penumbra, Inc., One Penumbra Place, Alameda, CA, USA.
  • Ford GA; Health Economics and Health Technology Assessment Research Group, University of Glasgow, Glasgow, UK.
  • Muhlemann N; Penumbra GmbH, Berlin, Germany.
  • Bath PM; Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
  • Abdul-Rahim AH; Health Economics, Assistance Publique Hôpitaux de Paris, Paris, France.
  • Sunnerhagen K; University of Oxford, UK.
  • Meretoja A; Nestle Health Science, Nestec S.A., Vevey, Switzerland.
  • Thijs V; Stroke Trials Unit, University of Nottingham, Nottingham, UK.
  • Weimar C; Institute of Neuroscience and Psychology, University of Glasgow, Glasgow, UK.
  • Massaro A; Section of Clinical Neuroscience, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Ranta A; Department of Medicine, University of Melbourne, Victoria, Australia.
  • Lees KR; Neurocenter, Helsinki University Hospital, Helsinki, Finland.
Eur Stroke J ; 5(2): 184-192, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32637652
INTRODUCTION: Approaches to economic evaluations of stroke therapies are varied and inconsistently described. An objective of the European Stroke Organisation (ESO) Health Economics Working Group is to standardise and improve the economic evaluations of interventions for stroke. METHODS: The ESO Health Economics Working Group and additional experts were contacted to develop a protocol and a guidance document for data collection for economic evaluations of stroke therapies. A modified Delphi approach, including a survey and consensus processes, was used to agree on content. We also asked the participants about resources that could be shared to improve economic evaluations of interventions for stroke. RESULTS: Of 28 experts invited, 16 (57%) completed the initial survey, with representation from universities, government, and industry. More than half of the survey respondents endorsed 13 specific items to include in a standard resource use questionnaire. Preferred functional/quality of life outcome measures to use for economic evaluations were the modified Rankin Scale (14 respondents, 88%) and the EQ-5D instrument (11 respondents, 69%). Of the 12 respondents who had access to data used in economic evaluations, 10 (83%) indicated a willingness to share data. A protocol template and a guidance document for data collection were developed and are presented in this article. CONCLUSION: The protocol template and guidance document for data collection will support a more standardised and transparent approach for economic evaluations of stroke care.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Eur Stroke J Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Eur Stroke J Año: 2020 Tipo del documento: Article Pais de publicación: Reino Unido